-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

321.P1.24 321. Blood Coagulation and Fibrinolytic Factors: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Biological, Bleeding Disorders, Coronaviruses, Hemophilia, SARS-CoV-2/COVID-19, Bleeding and Clotting, Diseases, Hemostasis, iPSCs, Non-Biological, Combinations, Therapies, Pediatric, Biological Processes, coagulant drugs, Thrombosis, Technology and Procedures, Cell Lineage, Study Population, Clinically relevant, Thrombocytopenias, Thrombotic Disorders, mass cytometry, Vascular Wall, molecular interactions, pathways, proteomics
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Peter Einersen1*, Sanchayita Mitra1*, Reid Selby2*, Ernest E. Moore, MD3*, Marguerite Kelher4*, Miguel Fragoso5*, Daran Schiller1*, Megan Swope6*, Geoffrey Nunns1*, Navin Vigneshwar1*, James Chandler1*, Arsen Ghasabayan7*, John Desisto8*, Bridget Sanford8*, Monika Dzieciatkowska, PhD5*, Linda Johnson9*, Mitchell J. Cohen10,11*, Angelo D’Alessandro, PhD12*, Erik Peltz13*, Anirban Banerjee, PhD14*, Kirk Hansen15*, Christopher C. Silliman, MD, PhD16 and Kenneth Jones2,8*

1Department of Surgery/Trauma Research Center, University of Colorado School of Medicine, Aurora, CO
2University of Oklahoma Health Sciences Center, Harold Hamm Diabetes Center, Oklahoma City, OK
3Surgery, Denver Health Medical Center, Denver, CO
4Univ of Colorado Denver/Bonfils Blood Center, Denver, CO
5University of Colorado Denver, Aurora, CO
6Ernest E Moore Shock Trauma Center, Denver Health Medical Center, Denver, CO
7Department of Surgery/Trauma Research Center,, University of Colorado School of Medicine, Aurora, CO
8Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO
9Department of Pathology, University of Colorado School of Medicine, Aurora, CO
10University of Colorado, Denver, CO
11Denver Health Medical Center/ University of Colorado, Denver, CO
12Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO
13University of Colorado, Aurora, CO
14Surgery, School of Medicine, University of Colorado Denver, Aurora, CO
15UC Denver, Aurora, CO
16Research Laboratory, Bonfils Blood Center, Denver, CO

Hang Chen1*, Luyi Peng2*, Jia Yu, BS2*, Xuan Yuan, MD, MSc3, Shruti Chaturvedi, MBBS, MS4, Robert Brodsky, MD2 and Evan M Braunstein, MD, PhD4

1Johns Hopkins University School of Medicine, Baltimore, MD, MD
2Johns Hopkins University, Baltimore, MD
3Hematology/Medicine, Johns Hopkins University School Medicine, Baltimore, MD
4Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Sandeep Subrahmanian, Ph.D.1*, Alain Borczuk, MD2*, Steven P. Salvatore, MD2*, Jeffrey Laurence, MD3 and Jasimuddin Ahamed, PhD1

1Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, OK
2Department of Pathology, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY
3Weill Cornell Medical College, New York, NY

Maria Eugenia Chollet, MD, PhD1,2*, Elisabeth Andersen, MSc, PhD1,2*, Maria Eugenia de la Morena-Barrio, PhD3,4*, Carlos Bravo-Perez, MD3,4*, Marie-Christine Mowinckel1,2*, Christiane Filion Myklebust, MSc1,2*, Ellen Skarpen, PhD5*, Bernd Thiede, PhD6*, Benedicte Stavik, PhD1,2*, Javier Corral, PhD3,4*, Gareth J Sullivan, PhD7,8* and Per Morten Sandset, MD, PhD1,2,9

1Department of Hematology, Oslo University Hospital, Oslo, Norway
2Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
3Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, University of Murcia, Murcia, Spain
4Centro Regional de Hemodonación, IMIB-Arrixaca, CIBERER, University of Murcia, Murcia, Spain
5Core Facility for Advanced Light Microscopy, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
6Department of Bioscience, University of Oslo, Oslo, Norway
7Norwegian Stem Cell Center, Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
8Department of Pediatrics, Oslo University Hospital, Oslo, Norway
9Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Reyes María Martín-Rojas, MD1*, Maite Chasco, MD2*, Sara Casanova, MD3*, Valeria Estefanía Delgado-Pinos, MD1*, Gloria Perez-Rus, MD, PhD1,4*, Patricia Duque, MD2*, Milagros Sancho, MD3*, Jose L. Diez-Martin, MD, PhD1,4,5 and Cristina Pascual Izquierdo, PhD, MD1,5*

1Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
2Department of Anesthesiology, Hospital General Universitario Gregorio Marañon, Madrid, Spain
3Intensive Care Unit, Hospital General Universitario Gregorio Marañon, Madrid, Spain
4Universidad Complutense de Madrid, Madrid, Spain
5Department of Hematology, Instituto de Investigación Sanitaria Gregorio Marañon, Madrid, Spain

Barbara A. Konkle, MD1,2, John Pasi, MB, ChB, PhD, FRCP, FRCPath, FRCPCH3, Annette von Drygalski, MD, Pharm D4, Toshko Lissitchkov5*, Roshni Kulkarni, MD6, Bent Winding7*, Stacey Poloskey8*, Suresh Katragadda8*, Stella Lin8*, Marek Demissie8* and Annemieke Willemze9*

1University of Washington, Seattle, WA
2University of Washington, Washington Center for Bleeding Disorders, Seattle, WA
3Royal London Haemophilia Centre, Barts and the London School of Medicine and Dentistry, London, United Kingdom
4Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, CA
5Department of Chemotherapy, Hemotherapy and Hereditary Blood Diseases at Clinical Hematology Clinic, Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria
6Michigan State University Center for Bleeding and Clotting Disorders, East Lansing, MI
7Swedish Orphan Biovitrum AB (Sobi), Stockholm, Sweden
8Sanofi, Waltham, MA
9Sanofi, Amsterdam, Netherlands

Sravya Kattula, PhD1*, Ane Salvador, PhD2*, Shaobin Wang, PhD3*, Ayman Ismail, PhD4*, Arjan van der Flier, PhD5*, Nina Leksa, PhD3* and Joe Salas, PhD6

1Rare Disorder: Hemophila, Sanofi, Waltham, MA
2Sanofi, Waltham, MA
3Rare Disorders: Hemophilia, Sanofi, Waltham, MA
4Rare Disorders: Hemophila, Sanofi, Waltham, MA
5Rare Disorders: Hemophilia, Sanofi, Somerville, MA
6Rare Disorders: hemophilia, Sanofi, Waltham, MA

Manuel Quintana, MD, PhD1*, Kapil Nanwani, MD, PhD1*, Charbel Maroun, MD, PhD2*, Elena Elena Muñoz, MD2*, Ana María Martínez, MD, PhD2*, Mar Gutierrez, MD3*, Elena G Arias-Salgado, PhD3*, Dolores Hernández-Maraver, MD4*, Ana Kerguelen Fuentes, MD, PhD4*, Rosario Torres, MD2*, Miguel A Canales, MD, PhD3,5, Aurora Viejo, MD4*, Nora V. Butta, PhD3*, María Teresa Alvarez Román, MD, PhD3* and Víctor Jiménez-Yuste, MD, PhD3,5*

1Intensive Care Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
2Emergency Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
3Hematology and Hemotherapy Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
4Transfusion Medicine, La Paz University Hospital-IdiPAZ, Madrid, Spain
5Universidad Autónoma de Madrid, Madrid, Spain

*signifies non-member of ASH